C12Y 304/24017
Stromelysin 1
Official title: Stromelysin 1 (3.4.24.17)
C12Y304/24017 (Stromelysin 1) appears on 27 US grants and 20 published applications in this corpus.
Search patents in C12Y- Granted patents
- 27
- Published applications
- 20
- Assignees
- 16
- Inventors
- 76
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 1 |
| 2003 | 1 | 2 |
| 2004 | 1 | 0 |
| 2005 | 3 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 0 |
| 2015 | 1 | 2 |
| 2016 | 1 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nano-engineered therapeutic stealth cells8 Apr 2025US 12,270,053 B2Ohio State Innovation Foundation
- Gelatinase inhibitors and prodrugs16 Jan 2018US 9,867,805 B2University of Notre Dame du Lac
- Gelatinase inhibitors and prodrugs26 Apr 2016US 9,321,754 B2University of Notre Dame du Lac
- Gelatinase inhibitors and prodrugs20 Jan 2015US 8,937,151 B2University of Notre Dame du Lac
- Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitor17 Jun 2014US 8,753,857 B2Janssen Pharmaceutica NV
- Fusions with proteases and uses thereof2 Jul 2026US 2026/0183373 A1Genentech, Inc.
- Nano-engineered therapeutic stealth cells14 Aug 2025US 2025/0257327 A1Ohio State Innovation Foundation
- Compositions and methods for ocular therapy17 Nov 2022US 2022/0362402 A1
- Nano-engineered therapeutic stealth cells9 Dec 2021US 2021/0380949 A1Ohio State Innovation Foundation
- Aav-based gene therapy for glaucoma28 Nov 2019US 2019/0358305 A1The Provost, Fellows, Scholars and Other Members of Board of Trinity College Dublin
Most cited
By later US patents
- 2'deoxy-2'-alkylnucleotide containing nucleic acid521US 5,627,053 ARibozyme Pharmaceuticals, Inc. · 1997
- RNA polymerase III-based expression of therapeutic RNAs154US 5,902,880 ARibozyme Pharmaceuticals, Inc. · 1999
- 2'-O-alkylthioalkyl and 2-C-alkylthioalkyl-containing enzymatic nucleic acids (ribozymes)127US 5,716,824 ARibozyme Pharmaceuticals, Inc. · 1998
- Methods for designing agents that interact with MMP-1395US 6,934,639 B1Wyeth · 2005
- Non-nucleotide containing enzymatic nucleic acid86US 6,117,657 ARibozyme Pharmaceuticals, Inc. · 2000